See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI102.37▼ 0.87%
← 0A44 page
XStocksXray
Market X-Ray report · 23 October 2026

Jumia Technologies AG (0A44)

London Exchange · UK · prices in USD · close of 23 Oct 2026

Key indicators

Last closeUSD 5.770
52-week range5.590 – 14.830
Return, 1 month / 3 months−16.3% / −2.4%
Return, 1 year / 3 years– / –
TrendBelow its 200-day average
RSI (14)36
Volatility (1 year)62.8%
Worst drawdown (1 year)-60.6%
Average daily value traded0.06M USD
Dividend yield–

Market X-Ray price-based

21/ 100 · Medium confidence · ahead of 10% of stocks on this exchange
Trend12
Momentum34
Stability (higher is calmer)15
Liquidity26
Income–

Five-year price chart navy: price · brown: 200-day average

5.157.5810.0212.4614.892025-122026-022026-052026-082026-10

About the company

Jumia Technologies AG runs an online marketplace that connects shoppers with sellers across several African countries. Its platform offers goods in categories such as electronics, fashion, home and beauty, alongside services including food delivery and payments. Customers are mainly consumers in African cities, while the company also works with local merchants and logistics partners. Jumia is headquartered in Berlin, Germany, and its operations are focused on African markets.

The shares are listed on the London Exchange in UK under the code 0A44, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Jumia Technologies AG (0A44) trades on the London Exchange in UK. It last closed at USD 5.770 on 23 October 2026.

Its price-based Market X-Ray is 21 out of 100 (a weak price profile), ranking 3,409 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Jumia Technologies AG (0A44)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend12 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-24.0%
From 52-week high-59.8%
Momentum34 · WeakLagging most stocks on this exchange.
3-month return-2.4%
6-month return-19.2%
12-month return, skipping the last month–
Stability (higher is calmer)15 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)62.8%
Worst drawdown, 1 year (smaller is calmer)-60.6%
Liquidity26 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.06M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−2.7%
1 month−16.3%
3 months−2.4%
6 months−19.2%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average6.693 / 7.596
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.333

Technical summary

DailyStrongly bearish2 bullish · 2 neutral · 11 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 6 bearish
MonthlyStrongly bearish0 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026